Alert detail

LCD L36129: MolDX: Biomarkers in Cardiovascular Risk Assessment — Palmetto GBA

Policy ID: LCD-L36129Specialty: CardiologyAdded: 9/12/2026Effective: March 21, 2024lcd
Low

What changed

Palmetto finalizes biomarker coverage rules for CV risk—doc requirements key.

Who’s affected: Cardiology billing teams · Effective: March 21, 2024

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 10 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.